Key result
Participation in Disease Specific Advance Care Planning was associated with a higher rate of having a health directive and increased hospice use among those who died.
Why the study?
Does Disease Specific Advance Care Planning (DS-ACP) improve advance care planning documentation and hospice use in heart failure patients?
Observational (n=1,894)
Does Disease Specific Advance Care Planning (DS-ACP) improve advance care planning documentation and hospice use in heart failure patients?
Answers are grounded in this paper and cite their sources.
Implementation of a Disease Specific Advance Care Planning model in heart failure patients significantly improves completion of health directives and increases hospice utilization at the end of life.
PURPOSE: This study evaluates the implementation of Disease Specific Advance Care Planning (DS-ACP) for heart failure patients in a large health care system. The DS-ACP model uses a trained facilitator to guide communication between patient and proxy regarding patient values and goals for treatment in worst-case scenarios, develop a disease specific documentation plan, and identify needed resources. METHODS: Referral and DS-ACP service delivery data were merged with electronic health record data. Process measures for implementation are described. Patients who participated in DS-ACP are compared with those who did not on demographics, medical characteristics, and outcomes such as inpatient readmissions, and hospice use among those who died. A chart audit was completed on a sample of patients to examine differences in advance care planning documentation between participants and nonparticipants. RESULTS: Nearly one third (31.8%) of the 1894 heart failure patients referred to DS-ACP participated. Referral method was associated with participation. A chart audit revealed 94.3% of those completing the DS-ACP process, had a health directive compared to 24.8% of noncompleters (p<0.001). Of the patients who died by the end of the study period (n=286), DS-ACP participants were more likely to have used hospice compared to nonparticipants (56% versus 37%, p=0.002). CONCLUSIONS: These initial evaluation results indicate the DS-ACP model, previously tested in randomized trials, can be successfully implemented among heart failure patients in a large health care system. Results demonstrate the importance of referral method and show initial positive results for participation, improved documentation, and hospice use.
No takes yet. Share an insight, caveat, or question.
Schellinger et al. (2011) conducted an observational in Heart failure (n=1,894). Disease Specific Advance Care Planning (DS-ACP) vs. Nonparticipants was evaluated on Having a health directive (p=<0.001). Participation in Disease Specific Advance Care Planning was associated with a higher rate of having a health directive and increased hospice use among those who died.
Synapse has enriched 10 related papers. Consider them for comparative context: